Cardiovascular risks of cyclooxygenase-2 inhibitors: where we stand now.
Finckh
Axel
A
Aronson
Mark D
MD
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D004335:Drug and Narcotic Control; D006801:Humans; D009203:Myocardial Infarction / Q000139:chemically induced*; D014481:United States
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors